KEY POINT SUMMARY – Musk Blindness
• Musk Blindness mission advances with new Neuralink brain chip
• First human trial to restore sight planned for late 2025
• Animal testing shows the chip can help blind subjects regain vision
• Neuralink filed trademarks for “Blindsight,” “telepathy,” and “telekinesis.”
• Full rollout will follow further testing and regulatory approval

Musk Blindness Mission Takes Major Step Forward

Elon Musk has revealed plans for a groundbreaking medical trial later this year. His brain tech company Neuralink, will implant its first sight-restoring chip, Blindsight, in a human.

The goal is clear. The chip will help those with complete blindness regain partial vision, marking a milestone for Musk’s ambitious Blindness initiative.

Neuralink’s Animal Trials Show Success

During a public event in Wisconsin, Musk detailed the chip’s progress. Tests on monkeys proved successful. He said the animals remain healthy after implantation.

“The first human test will offer low-resolution sight,” Musk admitted. “But eventually, vision could become superhuman.”

His remarks confirm what many speculated — that Musk’s Blindness solutions are advancing faster than expected.

Blindsight Trademarked As Neuralink Expands Ambitions

In recent weeks, Neuralink secured trademarks for “Blindsight,” “telepathy,” and “telekinesis.” These terms hint at the company’s far-reaching vision for human-computer interaction.

But for now, Musk Blindness efforts remain focused on restoring vision to those who need it most.

Neuralink Celebrates Earlier Success In Restoring Movement

Earlier in 2024, Neuralink’s implants helped patients with paralysis regain control over their limbs. Those trials marked the company’s first human success stories.

“Feedback from participants is invaluable,” Neuralink shared in a blog post. “It helps us refine designs and better meet users’ needs.”

Timeline For Widespread Use Still Unclear

Although Musk’s team is optimistic, the broader release of the Musk Blindness solution is still in the future. Regulatory approval and further tests are needed.

However, Musk believes the journey has begun. With human trials set for late 2025, hopes are high that Neuralink could soon help millions.